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Abstract 
Goals of work  After breast cancer treatment, women may experience significant and 
enduring problems relating to upper-body function (UBF) and quality of life (QoL). 
Women are often given advice to avoid problems, despite little scientific evidence to 
support or refute the advice given. 
Patients and methods  This study addressed the relationships between recovery advice 
and subsequent behaviours on QoL (Functional Assessment of Cancer Therapy, 
Breast questionnaire) and UBF (Disability of Arm, Shoulder and Hand questionnaire) 
6 months after treatment for unilateral breast cancer among a population-based 
sample of women residing in southeast Queensland (n=287). 
Main results  Eighty-seven percent (n=249) of women reported that they received 
advice on facilitating arm function during their hospital stay, whereas 72% received 
subsequent recovery advice from medical and/or allied health professionals. Reported 
QoL and UBF were similar between groups, irrespective of advice received. 
Behaviours of interest included adherence to advice given, participation in breast 
cancer programmes and whether women had flight travel, used the treated side as 
much as the untreated side or had trauma, sunburn, injections and/or blood pressure 
readings on the treated side in the previous 6 months. QoL and UBF were highest 
among those who followed minimal advice, who used their treated side as much as 
their untreated side and who did not participate in any breast cancer programme 
(p<0.05). 
Conclusions  The findings neither support nor refute current recommendations made 
to women with breast cancer, but rather raise questions about the value of this 
recovery advice. The study also provides novel findings regarding relationships 
between certain behaviours and QoL among breast cancer survivors. 




Breast cancer has had a significant impact on the health of women worldwide. Its 
estimated cost in Australia in 1993–1994 was $184 million [16]. However, it is more 
than simply a monetary expense, as it places emotional, psychosocial and physical 
burdens on patients and their families. These burdens are experienced by more than 
10,000 Australian women diagnosed with breast cancer every year [4]. Although 
breast cancer remains the leading form of cancer among women in many countries, 
there are now overall good prospects for survival partly due to early detection and 
improved treatment. Five-year relative survival increased from 72.3% for the 1982–
1986 period to 84.0% for the 1992–1997 period [3]. Unfortunately, survivorship is 
fraught with problems relating to upper-body function (UBF) and quality of life 
(QoL). To prevent complications, women are often given advice to avoid certain 
behaviours or to participate in specific activities. However, little scientific evidence is 
available to support or refute the common advice given. 
 
Between 16 and 43% of breast cancer patients experience heaviness, tightness, 
numbness, stiffness, lymphoedema, pain or reduced strength and range of motion on 
the treated side [11, 20, 23], with lymphoedema arguably being considered the most 
problematic and dreaded complication [18]. The presence of one or more of the above 
physical symptoms has the potential to adversely impact UBF, and in turn, QoL. 
Although function is most reduced during the first year after treatment, by 5 years 
post-diagnosis, approximately 40% of women continue to report some impairment in 
UBF, even after adjustment for specific patient, treatment and disease characteristics 
[13]. 
 
Although our understanding of the issues faced by breast cancer survivors has 
improved over the past decade, our understanding of how recovery advice and 
programme participation affect UBF and QoL remains limited. Hence, the ability to 
provide evidenced-based advice regarding the prevention of or recovery from these 
symptoms is limited, and most advice has generally been precautionary, e.g. take it 
easy and get some rest. However, evidence suggests that the impairment of physical 
capacity and QoL may be exacerbated by excessive rest [19]. 
 
Furthermore, the general recommendations for the prevention of lymphoedema, 
disseminated by various breast cancer [2, 6, 7, 17, 22] and lymphoedema [14] 
organisations throughout Australia and the United States [1], are largely based on 
anecdotal reports rather than systematic studies. Much of this educational material 
suggests behavioural modifications, which have originated from unsubstantiated dos 
and donts that have not changed in several decades, perhaps due to little rigorous 
research. Such recommendations urge women to avoid trauma, heat, carrying heavy 
loads, wearing constrictive clothing, injections and blood pressure readings on the 
affected side. Women are also advised to wear gardening gloves when gardening and 
rubber gloves when washing up to avoid burns/heat. Clearly, there is a need for 
further study regarding recovery-based guidelines, particularly when these 
recommendations involve considerable lifestyle changes and burden women 
psychologically, socially and emotionally (e.g. making the decision whether to wear a 
compression garment or not involves potential physical discomfort, social 
embarrassment and financial cost). 
 
This study investigated how participation or avoidance of breast cancer programmes, 




Patients and methods 
Subject group 
A total of 511 women were randomly selected through the Queensland Cancer 
Registry (QCR) for participation in this project. Eligible women were aged between 
20 and 74 years, diagnosed with unilateral breast cancer within the previous 6 months 
and resided within 100 km of Brisbane. Only women with a first diagnosis (no prior 
history) or invasive breast cancer were included. No exclusions were made on the 
basis of treatment. In accord with the QCR protocols, written consent was obtained 
from notifying medical practitioners for 417 women (81.6%) to allow recruitment into 




At 6 months post-diagnosis, participants were asked to complete a questionnaire to 
collect information about personal characteristics [i.e. age, income, physical activity, 
treated side with respect to dominance and complications after diagnosis (e.g. arm 
swelling)] and treatment undertaken (i.e. surgery, radiation, chemotherapy, hormone 
therapy and number of lymph nodes removed). Participants were also asked if they 
had received advice regarding recovery while in the hospital as well as subsequent 
advice from medical and/or allied health professionals, if they followed this advice 
and if they had participated in any programme specifically designed for women with 
breast cancer. Information was also obtained on specific behaviours undertaken, 
including whether women (1) had flight travel, (2) trauma to the treated side, (3) used 
the treated side as much as the untreated side or (4) had sunburn, (5) injections and/or 
(6) blood pressure readings on the treated side during the previous 6 months. 
 
QoL was assessed by the self-reported questionnaire, Functional Assessment of 
Cancer Therapy, Breast (FACT-B+4) [9, 10]. The total score ranges from 1 to 100 
with higher scores representing better well-being. The function/symptom scale of the 
Disability of Arm, Shoulder and Hand (DASH) questionnaire [21] was used to assess 
subjective UBF. The final score ranges from 0 to 100, whereby 0 reflects no disability 
(good function) and 100 reflects extensive disability (poor function). 
 
Outcome definitions and statistical methods 
Distributions of the FACT-B+4 scores were determined to be approximately normal, 
hence, were summarised as means with 95% confidence intervals (CIs). As DASH 
scores were not normally distributed, this outcome was categorised. The literature 
provides minimal guidance for categorising the DASH score, as previous work 
presented the raw continuous score despite absence of a normal distribution. Three 
methods, therefore, were applied to categorise the DASH scores for this work: (1) 
dichotomising the DASH score using the median [11], (2) using the frequency 
distribution to determine quintiles (0, 1–9, 10–19, 20–29 and 30+), (3) and following 
the American Academy of Orthopaedic Surgeons (AAOS) guidelines, which were 
developed to allow for comparative normative scores [12]. 
 
Bivariate statistics were then applied separately to the three DASH measures and each 
of several other outcomes available from the study, including objective measures of 
upper-body strength and endurance, mobility, hand grip strength and QoL measures. 
After this analysis, it was determined that the raw score and categorising according to 
the median provided the most appropriate outcome measures based on the statistical 
properties and the potential to yield robust results. Therefore, a score <11 was 
considered to represent good function (better then most), whereas 11+ represented 
poor function (worse then most); these were coded as 1 and 0, respectively, to make 
interpretation of findings similar to the analyses of the FACT-B+4, for which higher 
values denote better QoL. 
 
To explore associations with QoL, FACT-B+4 scores were subjected to four separate 
multiple linear regression models for (1) personal characteristics, (2) treatment 
characteristics, (3) recovery advice and participation in breast cancer programmes and 
(4) participation in certain behaviours. All models were adjusted for the co-variates of 
age, treatment on the dominant side and arm swelling. Variables that were 
theoretically (known from literature), statistically (p<0.05) or clinically (difference in 
mean of seven units [5]) important in the separate thematic models were retained and 
incorporated into two final models in order to explain influences from (1) recovery 
advice and (2) participation in certain behaviours. Results were expressed as adjusted 
means with 95% CI, with the conventional p<0.05 level (two-tailed) accepted as 
statistically significant. 
 
A similar process was applied using binary logistic regression to consider the 
independent associations with DASH scores using the same four thematic models. 
Again, the variables found to be theoretically, statistically or clinically [difference in 
odds ratios (ORs) >1.8 or <0.6] important were once again retained and incorporated 
into the two final models. Results were expressed as adjusted ORs and 95% CI, with 




Of the 287 women participating in this study, 4 were excluded from analyses of the 
FACT-B+4 outcome due to extensive missing data (n=283), and 29 were excluded 
from analyses of the DASH outcome (n=258). Demographic and disease 
characteristics were similar for the women in this study and those in the target sample 
(Table 1).  




NOS Not otherwise specified 
The mean FACT-B+4 score was 76.5 and ranged from 40.6 to 99.4. Approximately 
half of the sample (n=131, 50.8%) received a final DASH score of <11, indicating 
good UBF. Only one fifth of the group (n=65, 22.6%) reported that they had 
participated in any programme on breast cancer since being diagnosed. Eighty-seven 
percent (n=249) reported that they received advice regarding facilitating arm function 
during their hospital stay, whereas while 72% received subsequent recovery advice 
from medical and/or allied health professionals. The majority of women (n=255, 
88.9%) followed three or more of these specific recovery recommendations. Most 
women avoided flight travel, and trauma, sunburn, injections and/or blood pressure 
readings on the treated side, and used the operated arm as much as the unoperated arm 
during the previous 6 months (Table 2).  





Similar results were obtained in crude and adjusted analyses of patient and treatment 
characteristics with the outcomes, QoL and UBF (bivariate results shown in Table 3). 
Results for both QoL and UBF indicated positive relationships with age, income and 
physical activity, and negative relationships with number of lymph nodes removed. 
Women with young children (<14 years) reported lower QoL and were also 60% less 
likely to report good UBF than women who did not have any children in their care. 
Women who reported arm swelling reported lower QoL and were also less likely to 
report good UBF compared to women who did not experience arm swelling. No 
association between QoL and UBF was found for treatment on the dominant side.  
Table 3  Bivariate associations between QoL (FACT-B+4) or UBF (DASH) and 




QoL Quality of life, FACT-B+4 Functional Assessment of Cancer Therapy, Breast, 
UBF upper-body function, DASH Disability of Arm, Shoulder and Hand, DK do not 
know 
aIncludes those co-variates found to be statistically, clinically or theoretically 
important in thematic multivariate models (see Patients and methods) 
bOR of a DASH score <11.0 relative to DASH score of 11+ 
Table 4 presents relationships of recovery advice and specific behaviours with QoL 
(measured by FACT-B+4 scores) and UBF (measured by DASH), adjusting for 
personal and treatment characteristics. There was no association between QoL or UBF 
and advice received from medical and/or allied health professionals, either while in 
the hospital or subsequently outside of the hospital. QoL and UBF were higher among 
those who followed minimal advice and those who did not participate in any 
programme specifically designed for women with breast cancer. Women who 
followed minimal advice had a mean FACT-B+4 score of 83.5 compared with 75.7 
for those who followed three or more recommendations. Women who followed 
minimal advice were 3.3 times more likely to report better subjective UBF, compared 
with those who followed three or more recommendations, whereas those who 
participated in a breast cancer programme were 50% less likely to report better UBF 
compared with those who did not.  
Table 4  Multivariate associations of QoL (FACT-B+4) or UBF (DASH) with 
recovery advice (model 1) and with behavioural characteristics (model 2) after 




aAdjusted for all variables in Table 3 
bOR of a DASH score <11.0 relative to DASH score of 11+ 
QoL and UBF were higher among those who avoided trauma or injury to the operated 
side and for those who used the arm on the operated side as much as the other arm, 
compared with those who did not. Women who avoided trauma or injury had a mean 
FACT-B+4 score of 76.9 compared with 72.6 (67.8–77.3) for those who experienced 
trauma or injury to the operated side. Women who experienced trauma to the operated 
side were 50% less likely to report good UBF compared with those who did not 
(OR=0.5, 95% CI, 0.2–1.5, p=0.24). Women who used their arm on the operated side 
as much as their other arm were 3.6 times more likely to report good UBF compared 
with those who did not (OR=3.6, 95% CI, 1.8–7.0, p<0.001). There was no evidence 
for an association between QoL or UBF and either flight travel or blood pressure 
readings on the operated side. Results were inconsistent for the remaining behaviours, 
with some evidence that UBF was positively associated with sunburn but inversely 





The purpose of this paper was to assess the relationships between recovery advice and 
subsequent behaviours on QoL and UBF in women 6 months after treatment for 
unilateral breast cancer. In the analyses of advice setting, profession dispensing 
advice, amount of advice followed, participation in a breast cancer support 
programme and individual behaviours, we found little evidence for associations with 
either QoL or UBF in the direction expected based on current recommendations. 
These results, therefore, raise questions regarding the quality and effectiveness of 
advice regarding recovery after breast cancer diagnosis and treatment. 
 
There were a high percentage of women receiving advice while in hospital (86.8%) 
and subsequently outside of hospital (72.1%) from medical and/or allied health 
professionals. This is encouraging and potentially reflects the emerging literature on 
survivorship issues after breast cancer diagnosis as well as demonstrating that 
recovery after breast cancer treatment is receiving attention in the clinical setting. It is 
now important to ensure that the advice given is standardised across health 
professionals, evidence-based, practical and appropriately adhered to by women. 
Approximately 89% of the women surveyed followed three or more recommendations 
regarding recovery, highlighting their receptiveness and willingness to participate in 
activities that will aid recovery. 
 
Previous work has demonstrated the importance of receiving advice from a medical 
professional (breast cancer surgeon, radiation oncologist and medical oncologist), 
particularly with respect to those women who experienced a decline in UBF [13]. 
Although not statistically significant, those in this study who received advice from a 
medical professional reported higher QoL when compared with those who received 
advice only from allied health professionals. However, this is not a clear relationship, 
because those having problems at 6 months post-treatment (the time of this study) 
may be more likely to seek advice from allied health professionals in addition to or 
rather than medical professionals. Whether or not this advice was received during 
their hospital stay did not influence QoL or UBF at 6 months post-treatment. 
 
Although women seemed receptive and willing to adhere to advice, the majority of 
women (77.4%) did not participate in a programme specifically designed for breast 
cancer patients. Furthermore, QoL and UBF were higher among those who did not 
participate when compared with woman who attended the programmes. This could 
suggest that those most in need of the programmes are the ones attending, or 
conversely, the programmes are not effective in aiding QoL and UBF. The latter 
explanation seems unlikely based on anecdotal reports from programme participants 
and coordinators (unpublished findings). Nevertheless, more work is required within 
this field to ensure that the programme format is evidenced-based and to determine 
the extent to which these programmes influence recovery after breast cancer. If 
proved beneficial, the barriers leading to poor participation rates, such as access, 
timing, poor referral etc., must be addressed to ensure that public health benefits are 
attained. 
 
Although unsubstantiated by research, advice regarding participation in certain 
behaviours after breast cancer treatment seems to be relatively standard. Most women 
after breast cancer will avoid flight travel (77.0%) (or wear a constrictive stocking if 
flying) and will avoid sunburn (94.1%), injections (94.8%), trauma or injury (91.3%) 
and blood pressure readings (91.9%) on the treated side. Only one study could be 
found in the literature that investigated one of these recommendations, notably, flight 
travel. The study [8] suggested that flight travel was a precipitating factor in the 
development of lymphoedema. However, results were based on lymphoedema 
patients only (163 post-mastectomy patients with lymphoedema) and were compiled 
from answers to the question, What started (triggered) your lymphoedema (infection, 
insect bite, plant flight, burn, other, or unknown)? [8]. In contrast, the results of this 
study found no difference in QoL or UBF between those who had undergone flight 
travel in the previous 6 months, compared with those who had not. 
 
Advice regarding the use of the treated side is potentially less clear, with some reports 
suggesting that women should avoid carrying heavy items with the at risk arm, 
whereas in the same report stating that it is important that the limb be used in as 
normal a way as possible [15]. Women who used their treated side as much as their 
untreated side reported higher QoL and UBF when compared with those who did not. 
However, what is unclear is whether those women limiting the use of their treated 
side (approximately 33% of our sample) did so because they were physically 
incapable or because avoidance of using the treated side was the perceived correct 
thing to do. Those who had experienced injury or trauma to the treated side 
experienced lower QoL and UBF when compared to those who had not. This is not 
surprising and could support current recommendations. However, it seems unlikely 
that a woman would actively seek to experience trauma or injury to either side, and if 
women avoid using their treated side as a means of avoiding trauma, then the value of 
this recommendation should be questioned. There was some evidence also 
demonstrating that sunburn to the treated side was associated with better UBF. This is 
difficult to explain, except perhaps as a marker of outdoor activity, and was not 
supported by the QoL results. Also, whereas women who received injections on the 
treated side were 80% less likely to experience good UBF, the comparison group was 
small (n=12), and again, a similar association was not found for QoL. There was no 
evidence of an association, either way, between blood pressure readings on the treated 
side and either QoL or UBF. 
 
These are cross-sectional analyses, and therefore, inferences must be made with 
caution. However, this study includes a representative sample, and the conclusions 
derived from this work are likely generalisable to the wider population of women with 
unilateral breast cancer, aged 74 years or younger and residing in southeast 
Queensland. The population-based nature of the sample also suggests generalisability 
to other geographic settings, at least in westernised countries. The findings neither 
support nor refute the current recommendations made to women regarding 
participation in certain behaviours. Perhaps most importantly, these results raise 
questions about the value of recovery advice currently being given and provide novel 
findings regarding relationships between participation in certain behaviours and QoL 
and UBF. Considering the lack of evidence surrounding current recommendations, it 
seems unreasonable to expect or even encourage women to adjust their behaviours, 
particularly if this creates unnecessary worry and considerable lifestyle adjustments to 
accommodate these recommendations. Until guidelines become more evidence-based, 
health care professionals and women with breast cancer need to understand the limits 
and background to current recommendations. 
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